Tag: idct

idct

DiscGenics receives FDA fast track designation for disc degeneration cell therapy

DiscGenics has announced that the US Food and Drug Administration (FDA) has granted fast track designation for its investigational cell therapy, IDCT, currently being...

First patients treated in Japanese clinical trial of cell therapy for...

DiscGenics today announced the first patients have been treated in its Japanese safety study, a clinical trial of IDCT for mild to moderate degenerative...

Cell therapy IDCT passes initial safety review of first-in-human clinical trial...

It has been announced that IDCT (DiscGenics) has passed the initial planned safety review of its Phase I/II trial evaluating the allogeneic, injectable disc...

Clinical evaluation of non-surgical degenerative disc disease treatment to begin in...

The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved a Clinical Trial Notification (CTN) application for IDCT (DiscGenics), an allogenic injectable disc cell...

First patient treated in US clinical trial of IDCT for degenerative...

DiscGenics, a clinical stage regenerative medicine company, has announced the first patient has been treated in its phase I/II US clinical trial of IDCT...
DiscGenics logo

DiscGenics’ IDCT Investigational New Drug application accepted by US FDA

DiscGenics has been notified by the US Food and Drug Administration (FDA) that an Investigational New Drug (IND) application for a clinical study of...